Skip to main content

Advertisement

Log in

Nationwide study on the risk of unprovoked venous thromboembolism in non-traumatic osteonecrosis of femoral head

  • Original Paper
  • Published:
International Orthopaedics Aims and scope Submit manuscript

Abstract

Purpose

Endothelial dysfunction is a risk factor for osteonecrosis of femoral head (ONFH) and venous thromboembolism (VTE) [defined as deep venous thrombosis (DVT) or pulmonary embolism (PE)]. However, the risk of unprovoked VTE in non-traumatic ONFH patients remains unclear.

Methods

We investigated the relationship between ONFH and VTE using Taiwan National Health Insurance Research Database (NHIRD). Between 1997 and 2010, a total of 1514 non-traumatic ONFH patients were identified from 1,000,000 general populations after excluding initially concomitant diagnoses of DVT and PE, and subjects undergoing lower limb surgery within one year since enrollment. The comparison group (n = 15,140) without ONFH was set up by matching study cohort with age, gender, income and urbanization in a 1:10 ratio. Subjects diagnosed with VTE within one year after surgery were also excluded.

Results

The patients with non-traumatic ONFH had significantly higher frequency of unprovoked VTE, including DVT, than general population (1.19 vs. 0.5%, p < 0.0007), whereas the frequency of PE was similar between these two groups (p = 0.4922). The cumulative incidence of VTE and DVT was also remarkably higher in the ONFH than non-ONFH group (all p < 0.001). After adjusting for age, gender, medications and comorbidities with multivariate analysis, the ONFH patients had a 2.3-fold increase in risk of DVT compared with non-ONFH counterparts (95% CI 1.28 to 4.13, p = 0.0053). Apart from ONFH, age > 65 years and hypertension were also identified as risk factors for DVT occurrence.

Conclusions

The incidence and risk of unprovoked VTE were significantly increased in the non-traumatic ONFH population.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

Abbreviations

AVN:

Avascular necrosis

ONFH:

Osteonecrosis of femoral head

NO:

Nitic oxide

VTE:

Venous thromboembolic events

DVT:

Deep vein thrombosis

PE:

Pulmonary embolism

NHIRD:

National Health Insurance Research Database

NHRI:

National Health Research Institute

RAAS:

Renin-angiotensin-aldosterone system

References

  1. DiGiovanni CW, Patel A, Calfee R et al (2007) Osteonecrosis in the foot. J Am Acad Orthop Surg 15:208–217

    Article  PubMed  Google Scholar 

  2. Lafforgue P (2006) Pathophysiology and natural history of avascular necrosis of bone. Joint Bone Spine 73:500–507. https://doi.org/10.1016/j.jbspin.2006.01.025

    Article  PubMed  CAS  Google Scholar 

  3. Mont MA, Hungerford DS (1995) Non-traumatic avascular necrosis of the femoral head. J Bone Joint Surg Am 77:459–474

    Article  PubMed  CAS  Google Scholar 

  4. Agarwala S, Jain D, Joshi VR et al (2005) Efficacy of alendronate, a bisphosphonate, in the treatment of AVN of the hip. A prospective open-label study. Rheumatology 44:352–359. https://doi.org/10.1093/rheumatology/keh481

    Article  PubMed  CAS  Google Scholar 

  5. Wang CJ, Wang FS, Huang CC et al (2005) Treatment for osteonecrosis of the femoral head: comparison of extracorporeal shock waves with core decompression and bone-grafting. J Bone Joint Surg Am 87:2380–2387. https://doi.org/10.2106/jbjs.e.00174

    Article  PubMed  Google Scholar 

  6. Gangji V, Hauzeur J-P (2005) Treatment of osteonecrosis of the femoral head with implantation of autologous bone-marrow cells. J Bone Joint Surg Am:106–112

  7. Lieberman JR, Conduah A, Urist MR (2004) Treatment of osteonecrosis of the femoral head with core decompression and human bone morphogenetic protein. Clin Orthop Relat Res:139–145

  8. Myers TG, Cui Q, Kuskowski M et al (2006) Outcomes of total and unicompartmental knee arthroplasty for secondary and spontaneous osteonecrosis of the knee. J Bone Joint Surg Am 88(Suppl 3):76–82. https://doi.org/10.2106/jbjs.f.00568

    Article  PubMed  Google Scholar 

  9. Woo SB, Hellstein JW, Kalmar JR (2006) Systemic review: bisphosphonates and osteonecrosis of the jaws. Ann Intern Med 144:753–761

    Article  PubMed  CAS  Google Scholar 

  10. Chao YC, Wang SJ, Chu HC et al (2003) Investigation of alcohol metabolizing enzyme genes in Chinese alcoholics with avascular necrosis of hip joint, pancreatitis and cirrhosis of the liver. Alcohol Alcohol 38:431–436

    Article  PubMed  CAS  Google Scholar 

  11. Juery P (2007) Avascular necrosis after a steroid injection. CMAJ 176:814. https://doi.org/10.1503/cmaj.1060165

    Article  PubMed  PubMed Central  Google Scholar 

  12. Mankin HJ (1992) Nontraumatic necrosis of bone (osteonecrosis). N Engl J Med 326:1473–1479. https://doi.org/10.1056/nejm199205283262206

    Article  PubMed  CAS  Google Scholar 

  13. Chang CC, Greenspan A, Gershwin ME (1993) Osteonecrosis: current perspectives on pathogenesis and treatment. Semin Arthritis Rheum 23:47–69

    Article  PubMed  CAS  Google Scholar 

  14. Chim SM, Tickner J, Chow ST et al (2013) Angiogenic factors in bone local environment. Cytokine Growth Factor Rev 24:297–310. https://doi.org/10.1016/j.cytogfr.2013.03.008

    Article  PubMed  CAS  Google Scholar 

  15. Kerachian MA, Harvey EJ, Cournoyer D et al (2006) Avascular necrosis of the femoral head: vascular hypotheses. Endothelium 13:237–244. https://doi.org/10.1080/10623320600904211

    Article  PubMed  Google Scholar 

  16. Camporesi EM, Vezzani G, Bosco G et al (2010) Hyperbaric oxygen therapy in femoral head necrosis. J Arthroplast 25:118–123. https://doi.org/10.1016/j.arth.2010.05.005

    Article  Google Scholar 

  17. Wolberg AS, Rosendaal FR, Weitz JI et al (2015) Venous thrombosis. Nat Rev Dis Primers 1:15006. https://doi.org/10.1038/nrdp.2015.6

    Article  PubMed  Google Scholar 

  18. Hill JM, Zalos G, Halcox JP et al (2003) Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 348:593–600. https://doi.org/10.1056/NEJMoa022287

    Article  PubMed  Google Scholar 

  19. Deanfield JE, Halcox JP, Rabelink TJ (2007) Endothelial function and dysfunction testing and clinical relevance. Circulation 115:1285–1295

    PubMed  Google Scholar 

  20. Marti CN, Gheorghiade M, Kalogeropoulos AP et al (2012) Endothelial dysfunction, arterial stiffness, and heart failure. J Am Coll Cardiol 60:1455–1469. https://doi.org/10.1016/j.jacc.2011.11.082

    Article  PubMed  CAS  Google Scholar 

  21. Gresele P, Momi S, Migliacci R (2010) Endothelium, venous thromboembolism and ischaemic cardiovascular events. Thromb Haemost 103:56–61. https://doi.org/10.1160/th09-08-0562

    Article  PubMed  CAS  Google Scholar 

  22. Migliacci R, Becattini C, Pesavento R et al (2007) Endothelial dysfunction in patients with spontaneous venous thromboembolism. Haematologica 92:812–818

    Article  PubMed  CAS  Google Scholar 

  23. Cheng T-M (2009) Taiwan’s National Health Insurance system: high value for the dollar. In: Okma KGH, Crivelli L (eds) Six countries, six reform models: the health reform experience of Israel, the Netherlands, New Zealand, Singapore, Switzerland and Taiwan. World Scientific, New Jersey, pp 71–204

    Google Scholar 

  24. (2010) Venous thromboembolism: reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients admitted to hospital. National Clinical Guideline Centre-Acute and Chronic Conditions., London

  25. Rackwitz L, Eden L, Reppenhagen S et al (2012) Stem cell- and growth factor-based regenerative therapies for avascular necrosis of the femoral head. Stem Cell Res Ther 3:7. https://doi.org/10.1186/scrt98

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  26. (2012) Venous thromboembolic diseases: the management of venous thromboembolic diseases and the role of thrombophilia testing. National Clinical Guideline Centre., London

  27. Ceriello A, Quagliaro L, Piconi L et al (2004) Effect of postprandial hypertriglyceridemia and hyperglycemia on circulating adhesion molecules and oxidative stress generation and the possible role of simvastatin treatment. Diabetes 53:701–710

    Article  PubMed  CAS  Google Scholar 

  28. Brotman DJ, Deitcher SR, Lip GY et al (2004) Virchow’s triad revisited. South Med J 97:213–214. https://doi.org/10.1097/01.smj.0000105663.01648.25

    Article  PubMed  Google Scholar 

  29. Luo RB, Lin T, Zhong HM et al (2014) Evidence for using alendronate to treat adult avascular necrosis of the femoral head: a systematic review. Med Sci Monit 20:2439–2447. https://doi.org/10.12659/msm.891123

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  30. Gao F, Sun W, Li Z et al (2015) High-energy extracorporeal shock wave for early stage osteonecrosis of the femoral head: a single-center case series. Evid Based Complement Alternat Med 2015:468090. https://doi.org/10.1155/2015/468090

    Article  PubMed  PubMed Central  Google Scholar 

  31. Wang CJ, Cheng JH, Huang CC et al (2015) Extracorporeal shockwave therapy for avascular necrosis of femoral head. Int J Surg 24:184–187. https://doi.org/10.1016/j.ijsu.2015.06.080

    Article  PubMed  Google Scholar 

  32. Wassmann S, Laufs U, Baumer AT et al (2001) HMG-CoA reductase inhibitors improve endothelial dysfunction in normocholesterolemic hypertension via reduced production of reactive oxygen species. Hypertension 37:1450–1457

    Article  PubMed  CAS  Google Scholar 

  33. Ceriello A, Assaloni R, Da Ros R et al (2005) Effect of atorvastatin and irbesartan, alone and in combination, on postprandial endothelial dysfunction, oxidative stress, and inflammation in type 2 diabetic patients. Circulation 111:2518–2524. https://doi.org/10.1161/01.cir.0000165070.46111.9f

    Article  PubMed  CAS  Google Scholar 

  34. Ferrario CM, Strawn WB (2006) Role of the renin-angiotensin-aldosterone system and proinflammatory mediators in cardiovascular disease. Am J Cardiol 98:121–128. https://doi.org/10.1016/j.amjcard.2006.01.059

    Article  PubMed  CAS  Google Scholar 

  35. Fowkes FJ, Price JF, Fowkes FG (2003) Incidence of diagnosed deep vein thrombosis in the general population: systematic review. Eur J Vasc Endovasc Surg 25:1–5

    Article  PubMed  CAS  Google Scholar 

  36. Silverstein MD, Heit JA, Mohr DN et al (1998) Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med 158:585–593

    Article  PubMed  CAS  Google Scholar 

  37. Schmidt M, Christiansen CF, Horvath-Puho E et al (2011) Non-steroidal anti-inflammatory drug use and risk of venous thromboembolism. J Thromb Haemost 9:1326–1333. https://doi.org/10.1111/j.1538-7836.2011.04354.x

    Article  PubMed  CAS  Google Scholar 

  38. Ungprasert P, Srivali N, Wijarnpreecha K et al (2015) Non-steroidal anti-inflammatory drugs and risk of venous thromboembolism: a systematic review and meta-analysis. Rheumatology 54:736–742. https://doi.org/10.1093/rheumatology/keu408

    Article  PubMed  CAS  Google Scholar 

  39. Johannesdottir SA, Horvath-Puho E, Dekkers OM et al (2013) Use of glucocorticoids and risk of venous thromboembolism: a nationwide population-based case-control study. JAMA Intern Med 173:743–752. https://doi.org/10.1001/jamainternmed.2013.122

    Article  PubMed  CAS  Google Scholar 

  40. Barritt DW, Jordan SC (1960) Anticoagulant drugs in the treatment of pulmonary embolism. A controlled trial. Lancet 1:1309–1312

    Article  PubMed  CAS  Google Scholar 

  41. Konstantinides SV, Torbicki A, Agnelli G, et al. (2014) 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J 35:3033-3069, 3069a-3069k. https://doi.org/10.1093/eurheartj/ehu283

Download references

Acknowledgements

We would like to thank Institute of Occupational Medicine and Industrial Hygiene, College of Public Health, National Taiwan University, Taiwan for data acquisition. We also thank Health Information and Epidemiology Laboratory of Chang Gung Memorial Hospital, Chia-yi Branch, Taiwan (CLRPG6G0041) for the comments and assistance in data analysis. In addition, this study was supported by a grant from Chia-yi Chang Gung Memorial Hospital, and based on the National Health Insurance Research Database offered by the Bureau of National Health Insurance, Department of Health, Taiwan. We analyzed and interpreted the retrieved data for academic purpose, and therefore the viewpoint is not represented by the Bureau of National Health Insurance, Department of Health, or National Health Research Institutes.

Author information

Authors and Affiliations

Authors

Contributions

P.H.S and H.J.C. participated in the design of the study, data acquisition, and analysis as well as drafting the manuscript. Y.H.Y and C.J.C. were responsible for the data acquisition and troubleshooting. J.Y.C. and H.K.Y. participated in data analysis, and interpretation. M.S.L. conceived of the study, participated in its design and coordination, and helped to draft the manuscript. All authors read and approved the final manuscript.

Corresponding authors

Correspondence to Hon-Kan Yip or Mel S. Lee.

Ethics declarations

Conflict of interest

This article is the sole work of the authors. All authors report no conflict of interest.

Ethical review committee statement

This study was approved by the Ethics Institutional Review Board of Chang Gung Memorial Hospital (No. 201600738B1).

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sung, PH., Chiang, HJ., Yang, YH. et al. Nationwide study on the risk of unprovoked venous thromboembolism in non-traumatic osteonecrosis of femoral head. International Orthopaedics (SICOT) 42, 1469–1478 (2018). https://doi.org/10.1007/s00264-018-3866-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00264-018-3866-2

Keywords

Navigation